Skip to main content
. Author manuscript; available in PMC: 2020 Oct 20.
Published in final edited form as: Invest New Drugs. 2016 Jul 23;34(6):740–749. doi: 10.1007/s10637-016-0377-0

Fig. 2.

Fig. 2

Summary of drug-related adverse events by maximum toxicity grade across all dose combinations. a The category of rash was comprised of the following collapsed preferred terms: dermatitis acneiform, erythema, rash, rash erythematous, rash macular, and rash maculo-papular. b The category of mucositis was comprised of the following collapsed preferred terms: aphthous stomatitis, mouth ulceration, mucosal inflammation, and stomatitis